CytRx Corporation (CYTR) Announces Pricing of Public Offering of 10.0 Million Shares of Common Stock
10/9/2013 11:10:51 AM
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the pricing of its previously announced underwritten public offering. CytRx is offering 10.0 million shares of common stock at a public offering price of $2.25 per share for gross proceeds of $22.5 million, prior to deducting the underwriting discount and estimated offering expenses payable by CytRx.
Help employers find you! Check out all the jobs and post your resume.
comments powered by